HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Naganuma Selected Research

P-300

8/2019Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infection.
4/2018Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis.
1/2018Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsushi Naganuma Research Topics

Disease

29Hepatocellular Carcinoma (Hepatoma)
10/2022 - 06/2002
13Neoplasms (Cancer)
08/2022 - 04/2007
12Infections
01/2021 - 04/2002
8Neoplasm Metastasis (Metastasis)
08/2022 - 01/2008
8Chronic Hepatitis C
05/2022 - 04/2002
7Hepatitis C
04/2022 - 04/2002
7Liver Cirrhosis (Hepatic Cirrhosis)
04/2022 - 01/2013
7Fibrosis (Cirrhosis)
12/2021 - 03/2017
6Autoimmune Hepatitis
01/2020 - 01/2013
3Fatigue
06/2022 - 03/2020
3Ascites
05/2022 - 10/2020
3Esophageal and Gastric Varices (Esophageal Varices)
04/2022 - 12/2021
3Thrombosis (Thrombus)
02/2022 - 05/2007
3Virus Diseases (Viral Diseases)
01/2021 - 04/2007
2Edema (Dropsy)
05/2022 - 04/2021
2Portal Hypertension
04/2022 - 04/2022
2Stomach Neoplasms (Stomach Cancer)
01/2022 - 05/2018
2Liver Neoplasms (Liver Cancer)
12/2021 - 08/2021
2Hypertriglyceridemia
10/2021 - 07/2021
2Fatty Liver
10/2021 - 07/2021
2Microsatellite Instability
09/2020 - 02/2004
2Massive Hepatic Necrosis
10/2016 - 06/2016
1Carcinoma (Carcinomatosis)
09/2022
1Proteinuria
08/2022
1Diarrhea
06/2022
1Hypothyroidism
06/2022
1Persistent Infection
05/2022
1Falciparum Malaria (Plasmodium falciparum Malaria)
05/2022
1Hematemesis
04/2022
1Hypertension (High Blood Pressure)
03/2022
1End Stage Liver Disease
02/2022
1Sarcopenia
02/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1Non-alcoholic Fatty Liver Disease
10/2021
1Disease Progression
10/2021
1Alcoholic Fatty Liver
07/2021
1Noonan Syndrome (Female Pseudo-Turner Syndrome)
07/2021
1Cerebral Infarction
06/2021
1Jaundice (Icterus)
04/2021
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
04/2021
1Cachexia
04/2021
1Biliary Fistula
02/2021
1Brain Diseases (Brain Disorder)
01/2021
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2021

Drug/Important Bio-Agent (IBA)

11BilirubinIBA
02/2022 - 08/2019
10Bevacizumab (Avastin)FDA Link
10/2022 - 01/2021
10atezolizumabIBA
10/2022 - 01/2021
10lenvatinibIBA
06/2022 - 03/2020
9Antiviral Agents (Antivirals)IBA
04/2022 - 04/2002
9AlbuminsIBA
02/2022 - 03/2020
8Proteins (Proteins, Gene)FDA Link
05/2022 - 06/2002
5glecaprevir and pibrentasvirIBA
05/2022 - 01/2018
5Sorafenib (BAY 43-9006)FDA Link
08/2021 - 08/2017
5InterferonsIBA
09/2018 - 04/2002
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2022 - 10/2013
4Serum AlbuminIBA
02/2022 - 01/2021
4RNA (Ribonucleic Acid)IBA
10/2019 - 04/2012
4Ribavirin (Virazole)FDA LinkGeneric
02/2018 - 08/2011
3C-Reactive ProteinIBA
10/2022 - 01/2022
3Tumor Biomarkers (Tumor Markers)IBA
08/2022 - 01/2022
3ZincIBA
02/2022 - 11/2006
3SofosbuvirIBA
01/2021 - 02/2018
3Carrier Proteins (Binding Protein)IBA
01/2020 - 12/2018
3P-300IBA
08/2019 - 01/2018
2Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 05/2007
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2021 - 09/2018
2(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA
10/2021 - 07/2021
2Messenger RNA (mRNA)IBA
05/2020 - 10/2016
2pibrentasvirIBA
12/2019 - 01/2018
2glecaprevirIBA
12/2019 - 01/2018
2ChemokinesIBA
08/2019 - 12/2018
2NucleotidesIBA
01/2019 - 10/2016
28- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA
09/2018 - 03/2017
2daclatasvirIBA
09/2018 - 03/2017
2asunaprevirIBA
09/2018 - 03/2017
2Cisplatin (Platino)FDA LinkGeneric
05/2018 - 05/2007
2AntibodiesIBA
01/2017 - 01/2013
2Pharmaceutical PreparationsIBA
10/2013 - 04/2012
1Urea (Carbamide)FDA LinkGeneric
05/2022
1RivaroxabanIBA
02/2022
1Zinc AcetateFDA Link
02/2022
1NivolumabIBA
01/2022
1acarboxyprothrombin (PIVKA)IBA
01/2022
1Leucovorin (Folinic Acid)FDA Link
01/2022
1Irinotecan (Camptosar)FDA LinkGeneric
01/2022
1regorafenibIBA
08/2021
1Therapeutic UsesIBA
07/2021
1Imatinib Mesylate (Gleevec)FDA Link
04/2021
1DiureticsIBA
04/2021
1Formaldehyde (Formol)FDA Link
01/2021

Therapy/Procedure

18Therapeutics
06/2022 - 04/2002
4Drug Therapy (Chemotherapy)
09/2020 - 05/2007
2Immunotherapy
10/2022 - 01/2021
2Hepatectomy
08/2022 - 02/2022
1Plasma Exchange
05/2022
1Ligation
04/2022
1Length of Stay
06/2021
1Nutritional Support (Artificial Feeding)
04/2021
1Radiofrequency Ablation
04/2021
1Aftercare (After-Treatment)
02/2021